Literature DB >> 24409377

Photons across medicine: relating optical and nuclear imaging.

Robert Nordstrom1, Simon Cherry2, Ali Azhdarinia3, Eva Sevick-Muraca3, Henry Vanbrocklin4.   

Abstract

The Optics in the Life Sciences conference sponsored by the Optical Society of America was held in Waikoloa Beach, HI on April 14 - 18, 2013. Papers were presented in the areas of Bio-Optics: Design & Application, Novel Techniques in Microscopy, Optical Molecular Probes, Imaging & Drug Delivery, and Optical Trapping Applications. A focal point of the meeting was a special symposium entitled "Photons Across Medicine", organized by Adam Wax, Duke University, highlighting activities of joint interest between the Optical Society of America (OSA) and the Society for Nuclear Medicine and Molecular Imaging (SNMMI). This paper is a synopsis of the presentations made at this joint symposium. Central to the special symposium presentations was the fact that the optical and nuclear imaging communities share common interests and challenges. These are highlighted in this article. Also discussed was the fact that the nuclear technologies in imaging have found their way into general clinical utility, a feat that has yet to be achieved by optical methods. Because of the common ground shared by the two technologies, coordination between the two societies should be planned.

Entities:  

Keywords:  (170.0110) Imaging systems; (170.0170) Medical optics and biotechnology; (170.3880) Medical and biological imaging; (170.3890) Medical optics instrumentation

Year:  2013        PMID: 24409377      PMCID: PMC3862159          DOI: 10.1364/BOE.4.002751

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  36 in total

1.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

Review 2.  Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging.

Authors:  Yingding Xu; Hongguang Liu; Zhen Cheng
Journal:  J Nucl Med       Date:  2011-11-11       Impact factor: 10.057

Review 3.  Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label.

Authors:  Joeri Kuil; Aldrik H Velders; Fijs W B van Leeuwen
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

4.  FPGA Electronics for OPET: A Dual-Modality Optical and Positron Emission Tomograph.

Authors:  Ali Douraghy; Fernando R Rannou; Robert W Silverman; Arion F Chatziioannou
Journal:  IEEE Trans Nucl Sci       Date:  2008-10-01       Impact factor: 1.679

Review 5.  Small animal SPECT and its place in the matrix of molecular imaging technologies.

Authors:  Steven R Meikle; Peter Kench; Michael Kassiou; Richard B Banati
Journal:  Phys Med Biol       Date:  2005-10-24       Impact factor: 3.609

Review 6.  The cost of developing imaging agents for routine clinical use.

Authors:  Adrian D Nunn
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

Review 7.  Antibodies and antimatter: the resurgence of immuno-PET.

Authors:  Anna M Wu
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

8.  Simultaneous PET and multispectral 3-dimensional fluorescence optical tomography imaging system.

Authors:  Changqing Li; Yongfeng Yang; Gregory S Mitchell; Simon R Cherry
Journal:  J Nucl Med       Date:  2011-08       Impact factor: 10.057

9.  Editorial: The real gap between bench and bedside.

Authors:  S Wolf
Journal:  N Engl J Med       Date:  1974-04-04       Impact factor: 91.245

Review 10.  Recent developments in PET detector technology.

Authors:  Tom K Lewellen
Journal:  Phys Med Biol       Date:  2008-08-11       Impact factor: 3.609

View more
  1 in total

Review 1.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.